2022-07-05-世界卫生组织-Immunization_Ireland_2022_country_profile_16页_351kb

报告摘要

WHO and UNICEF estimates are country-specific, based on a combination of reported data, administrative records, surveys, and demographic adjustments.
Grade of Confidence (GoC) reflects empirical support: ••• (well-supported but risky), •• (supported; no challenges), • (no support/challenge).
No empirical data from independent assessments in recent years.
COVID-19 impacted 2020 coverage; Q2 was lower, but returned to pre-pandemic levels by Q3.
For some vaccines, data reflects partial years or is calibrated to previous levels due to gaps.
Estimates begin from 2010 and include various vaccine series.

BCG: Annoyingly low in recent years (e.g., >70% stock-outs reported in 2016-2017), with estimates around 30-76% varying by year.
DTP1, DTP3: High coverage (94-98%) from 2015-2021, with GoC indicating supported data.
Pol3: Consistently high (94-96%), supported by reported data.
IPV1: Limited data, GoC "No accepted empirical," coverage stable around 95-98%.
MCV1: High coverage (90-96%), with some years calibrated.
MCV2: No published estimates.
RCV1: Estimated based on MCV1, coverage 90-95% GoC similar to MCV1.
HepBB: No published estimates.
HepB3: Coverage increased from low levels (e.g., 46% in 2010 to 95-95% GoC in later years).
Hib3: High coverage (~95-96%), supported data.
RotaC: Coverage around 89-91% since 2017, GoC supported.
PcV3: Stable around 90-92%, with introduction in 2008, GoC suggested data reliability.

COVID-19 Impact: 2020 Q2 coverage dip; values returned to normal by Q3.
Data Limitations: No nationally representative independent assessments in years. Many estimates rely on reported data and UN Population Division recalculations.
Stock-Outs and Calibration: Issues in 2016-2017 affected programmatic data.

Estimates to be used with caution; no assessments are perfect, and risks exist based on data limitations.
Next revision expected July 15, 2023, with data as of July 7, 2022.

展开完整摘要